NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Chief Accounting Officer Louise Frederika Kooij sold $5.2M of NewAmsterdam Pharma Company N.V.
Sold$5,196,741
$35.84Price
145,000Shares
−91%Stake
What NAMS did after the filing
- The stock from Mon, Dec 29 close, $35.02
- −2.2%
- S&P 500, same days
- +0.6%
Measured over 30 trading days, to the Feb 11 close.
Traded Tue, Dec 23. Filed Mon, Dec 29, 12:14 PM ET, during the session. Returns use the Dec 29 close and the Feb 11 close. Not investment advice.